HOXC-AS2
gene geneOn this page
Summary
HOXC-AS2 (HOXC cluster antisense RNA 2, HGNC:43750) is a long non-coding RNA gene on chromosome 12q13.13.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:43750 |
| Approved symbol | HOXC-AS2 |
| Name | HOXC cluster antisense RNA 2 |
| Location | 12q13.13 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000250133 |
| Ensembl biotype | lncRNA |
| Entrez | 100874364 |
| RNAcentral | URS00000F783F — lncRNA, 504 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 lncRNA, 1 retained_intron
ENST00000513533, ENST00000604081
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000513533 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002050334 | 53995208 | 53995518 |
| ENSE00002057019 | 53995833 | 53995909 |
| ENSE00002079290 | 53996670 | 53996785 |
Expression profiles
Bgee: expression breadth broad, 89 present calls, max score 82.47.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2878 / max 12.6934, expressed in 163 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 131288 | 0.2560 | 149 |
| 131289 | 0.0318 | 9 |
Top tissues by expression
89 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.47 | gold quality |
| metanephros cortex | UBERON:0010533 | 77.04 | gold quality |
| left uterine tube | UBERON:0001303 | 74.06 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 73.71 | gold quality |
| kidney | UBERON:0002113 | 72.47 | gold quality |
| cortex of kidney | UBERON:0001225 | 72.45 | gold quality |
| muscle of leg | UBERON:0001383 | 71.92 | gold quality |
| gastrocnemius | UBERON:0001388 | 71.76 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 71.50 | gold quality |
| popliteal artery | UBERON:0002250 | 71.20 | gold quality |
| tibial artery | UBERON:0007610 | 71.15 | gold quality |
| sural nerve | UBERON:0015488 | 69.71 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 69.03 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 67.73 | gold quality |
| tibial nerve | UBERON:0001323 | 66.64 | gold quality |
| fallopian tube | UBERON:0003889 | 66.05 | gold quality |
| skin of leg | UBERON:0001511 | 64.68 | gold quality |
| zone of skin | UBERON:0000014 | 64.10 | gold quality |
| skin of abdomen | UBERON:0001416 | 63.54 | gold quality |
| calcaneal tendon | UBERON:0003701 | 60.87 | gold quality |
| adipose tissue | UBERON:0001013 | 60.13 | gold quality |
| multicellular organism | UBERON:0000468 | 60.05 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 59.43 | gold quality |
| small intestine | UBERON:0002108 | 57.52 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 57.51 | gold quality |
| right ovary | UBERON:0002118 | 57.46 | gold quality |
| ventricular zone | UBERON:0003053 | 57.16 | silver quality |
| placenta | UBERON:0001987 | 56.93 | gold quality |
| left ovary | UBERON:0002119 | 55.60 | gold quality |
| ovary | UBERON:0000992 | 55.53 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.80 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- The HOXC-AS2/miR-876-5p/HKDC1 axis regulates endometrial cancer progression in a high glucose-related tumor microenvironment. (PMID:35485648)
- LncRNA-HOXC-AS2 regulates tumor-associated macrophage polarization through the STAT1/SOCS1 and STAT1/CIITA pathways to promote the progression of non-small cell lung cancer. (PMID:38168631)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.